Skip to main content

MIT Corporate Relations

MIT Corporate Relations
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (0)
  • Videos (19)
  • Events (0)
  • Startup Opportunities (5)
  • Startups
  • Founders
Please sign-in to see the full search results
32 search results found
  • Immunai

    New York, NY
    Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.
    Keywords:
    single-cell sequencing, single-cell genomics, machine learning, Artificial Intelligence
    Immunai logo
  • Cracking Cancer 2.0 - Lightning Talks

    Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

  • Cell-Chorus-DemoDay

    12.8.21-DemoDay-Daniel-Meyer

    December 8, 2021 | Startup Exchange Video | Duration: 6:47
    CellChorus: Dynamic single-cell analysis at scale
  • Past Deadline: Sep 29, 2020

    Speak at Healthcare Series: Precision Medicine in Oncology 10/16

    speaker

    Seeking 2-3 startups to participate in the ILP Healthcare Series: Approaches to Precision Medicine in Oncology on October 16, 2020.

  • Past Deadline: Nov 12, 2020

    Global mining company seeks solutions for protective anode coating for aluminum smelting

    partnership

    Rio Tinto is seeking a solution to apply a proprietary protective coating onto baked carbon anodes that are used during the production of aluminium.

  • Past Deadline: Jun 15, 2020

    P&G seeks startups for Sensor/IoT/Monitoring to resolve Industrial Clogging/Caking

    other

    P&G is looking for partners and solutions that can help improve their premix production process, specifically resolving clogging/caking issues during the industrial process of powder dumping.

  • Past Deadline: Sep 14, 2022

    P&G seeks startups for Automated Mixed SKU Palletizing

    other

    P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.

  • DUST Identity

    Newton, MA
    Technology
    DUST -- the Diamond Uncloneable Security Tag -- is a proprietary technology which utilizes nanodiamonds to create an unclonable identity layer on any object. An optical scanner and cloud-based infrastructure provides an interface to the object identity and provenance. DUST ensures that trusted data... More
    Keywords:
    #supplychain #security #nanotech #cybersecurity #IoT #blockchain #counterfeit #trackandtrace
    DUST Identity logo
  • Collins-Synthetic Biology

    Synthetic Biology Workshop 2017 - Academic Keynote - Innovations in Synthetic Biology

    September 12, 2017 | Startup Exchange Video | Duration: 16:38

    James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.

  • Asimov, Inc.

    Cambridge, Massachusetts
    Biotechnology
    Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More
    Asimov-color

Pagination

  • of 4
  • 1
  • 2
  • 3
  • 4
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations